GCT Cells

The GCT cell line, originating from a giant cell tumor (GCT) isolated from the lung of an adult male patient with fibrous histiocytoma, is renowned for its robust biological activity in the field of medical research. This line produces Colony Stimulating Activity (CSA) for human granulocyte precursors and Erythropoietin-like Erythroid Activity (EEA) for erythroid precursors, making it invaluable for studying the regulation and development of hematopoietic cells. The granulocyte and erythroid precursors targeted by the GCT cell line’s products are key to understanding processes like neutrophil function in the immune response and red blood cell formation, respectively.

Additionally, the medium conditioned by this cell line is a significant source of prostaglandin E and plasminogen activator. These substances have crucial roles in inflammatory responses and the fibrinolytic pathway, respectively. Prostaglandin E is essential for inflammatory modulation and maintaining physiological balance, while plasminogen activator contributes to the dissolution of blood clots. The presence of these factors in the GCT cell line’s conditioned medium underscores its potential for developing therapeutic strategies addressing cardiovascular diseases and conditions related to excessive clot formation and inflammation.